A Phase IIb, Multicenter, Double-blind, Placebo-controlled Induction Study With an Active Treatment Extension to Assess the Efficacy, Safety, and Pharmacokinetics of RO7837195 in Patients With Moderately to Severely Active Ulcerative Colitis
Latest Information Update: 26 May 2025
At a glance
- Drugs Anti-inflammatories
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Sponsors Genentech
Most Recent Events
- 26 May 2025 New trial record